20 Dec 2019 by admin in UncategorizedComments Syros Announces Appointment of Mark Alles to Its Board of Directors
18 Dec 2019 by admin in UncategorizedComments GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia
03 Dec 2019 by admin in UncategorizedComments Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Pipeline Candidate CNTX-4975
